4.7 Article

We Can Change the Natural History of Type 2 Diabetes

期刊

DIABETES CARE
卷 37, 期 10, 页码 2668-2676

出版社

AMER DIABETES ASSOC
DOI: 10.2337/dc14-0817

关键词

-

资金

  1. National Institutes of Health [DK066204, UL1 RR025008]
  2. VA award HSRD IIR [07-138]
  3. Cystic Fibrosis Foundation [PHILLI12A0]
  4. National Center for Advancing Translational Sciences [UL1TR000083]
  5. U.S. Department of Veterans Affairs
  6. ADA
  7. [P30 DK017047]

向作者/读者索取更多资源

As diabetes develops, we currently waste the first similar to 10 years of the natural history. If we found prediabetes and early diabetes when they first presented and treated them more effectively, we could prevent or delay the progression of hyperglycemia and the development of complications. Evidence for this comes from trials where lifestyle change and/or glucose-lowering medications decreased progression from prediabetes to diabetes. After withdrawal of these interventions, there was no catch-up-cumulative development of diabetes in the previously treated groups remained less than in control subjects. Moreover, achieving normal glucose levels even transiently during the trials was associated with a substantial reduction in subsequent development of diabetes. These findings indicate that we can change the natural history through routine screening to find prediabetes and early diabetes, combined with management aimed to keep glucose levels as close to normal as possible, without hypoglycemia. We should also test the hypothesis with a randomized controlled trial.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, Research & Experimental

Medically tailored meals for food insecurity and type 2 diabetes: Protocol for the food as medicine for diabetes (FAME-D) trial

Seth A. Berkowitz, Gina R. Kruse, Katharine A. Ball Ricks, Jessica Burch, Ethan Ouimet, Beth Kitzis, Colleen Forrest, Jean Terranova, Paul W. Stewart, John B. Buse, Thomas C. Keyserling, Deborah J. Wexler, Linda M. Delahanty

Summary: This article describes a trial protocol to assess whether medically tailored meals plus lifestyle intervention can improve hemoglobin A1c and participant-reported outcomes compared to a food subsidy for adults with both type 2 diabetes and food insecurity. The trial aims to enroll 200 participants and will use a pragmatic design with random assignment to different interventions. The primary outcome is hemoglobin A1c at 6 months. The results will inform clinical management of food insecurity in the context of type 2 diabetes.

CONTEMPORARY CLINICAL TRIALS (2023)

Editorial Material Endocrinology & Metabolism

The Times They Are A-Changin' at Diabetes Care

Steven E. Kahn, Cheryl A. M. Anderson, John B. Buse, Elizabeth Selvin, Sonia Y. Angell, Vanita R. Aroda, Jessica R. Castle, Alice Y. Y. Cheng, Thomas Danne, Justin B. Echouffo-Tcheugui, Jose C. Florez, Meghana D. Gadgil, Amalia Gastaldelli, Jennifer B. Green, Ania M. Jastreboff, Alka M. Kanaya, Namratha R. Kandula, Csaba P. Kovesdy, Neda Laiteerapong, Kristen J. Nadeau, Rodica Pop-Busui, Camille E. Powe, Casey M. Rebholz, Michael R. Rickels, Naveed Sattar, Jonathan E. Shaw, Emily K. Sims, Kristina M. Utzschneider, Adrian Vella, Cuilin Zhang

DIABETES CARE (2023)

Editorial Material Endocrinology & Metabolism

The Art of Diabetes Care

Steven E. Kahn, Cheryl A. M. Anderson, John B. Buse, Elizabeth Selvin

DIABETES CARE (2023)

Article Endocrinology & Metabolism

Impact of Expanding Access to Continuous Glucose Monitoring Systems Among Insulin Users with Type 1 or Type 2 Diabetes

Shweta Pathak, Kristina Kearin, Anna R. Kahkoska, Kathryn A. Fuller, Bradley Staats, Joseph Albright, Til Sturmer, John B. Buse, Benjamin Y. Urick

Summary: A policy change by a commercial insurer expanded coverage of continuous glucose monitoring (CGM) through the pharmacy benefit, leading to increased utilization of CGM. The study found that CGM use significantly increased after the policy change, especially among type 1 diabetes mellitus (T1DM) patients. The findings suggest that the policy change had a positive impact on CGM utilization.

DIABETES TECHNOLOGY & THERAPEUTICS (2023)

Article Computer Science, Interdisciplinary Applications

A method for comparing multiple imputation techniques: A case study on the US national COVID cohort collaborative

Elena Casiraghi, Rachel Wong, Margaret Hall, Ben Coleman, Marco Notaro, Michael D. Evans, Jena S. Tronieri, Hannah Blau, Bryan Laraway, Tiffany J. Callahan, Lauren E. Chan, Carolyn T. Bramante, John B. Buse, Richard A. Moffitt, Til Sturmer, Steven G. Johnson, Yu Raymond Shao, Justin Reese, Peter N. Robinson, Alberto Paccanaro, Giorgio Valentini, Jared D. Huling, Kenneth J. Wilkins

Summary: Healthcare datasets from Electronic Health Records are valuable for assessing associations between patients' predictors and outcomes. However, missing values are common in these datasets, and removing them may introduce bias. Multiple imputation algorithms have been proposed to recover missing information, but there is no consensus on which algorithm works best. Choosing algorithm parameters and data-related modeling choices is also challenging.

JOURNAL OF BIOMEDICAL INFORMATICS (2023)

Editorial Material Endocrinology & Metabolism

Reducing Bias in Academic Publishing: The Diabetes Care Approach

Steven E. Kahn, Cheryl A. M. Anderson, Mark A. Atkinson, George L. Bakris, John B. Buse, Frank B. Hu, Stephen S. Rich, Matthew C. Riddle, Elizabeth Selvin

DIABETES CARE (2023)

Article Endocrinology & Metabolism

Study design and baseline profile for adults with type 2 diabetes in the once-weekly subcutaneous SEmaglutide randomized PRAgmatic (SEPRA) trial

John B. Buse, Helene Nordahl Christensen, Brian J. Harty, Julie Mitchell, Benjamin P. Soule, Emily Zacherle, Mark Cziraky, Vincent J. Willey

Summary: SEPRA is an ongoing pragmatic clinical trial that aims to compare the effects of once-weekly subcutaneous semaglutide with standard care in patients with type 2 diabetes. It collects data from routine clinical practice to support decision-making by clinicians, payers, and policy makers. Key outcomes of the study include glycemic control, weight loss, healthcare utilization, and patient-reported outcomes.

BMJ OPEN DIABETES RESEARCH & CARE (2023)

Biographical-Item Endocrinology & Metabolism

Daniel Porte Jr, 13 August 1931-13 May 2023

Steven E. Kahn, Michael W. Schwartz

DIABETOLOGIA (2023)

Article Medicine, Research & Experimental

Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes

Jessica A. Regan, Robert J. Mentz, Maggie Nguyen, Jennifer B. Green, Lauren K. Truby, Olga Ilkayeva, Christopher B. Newgard, John B. Buse, Harald Sourij, C. David Sjostrom, Naveed Sattar, Robert W. Mcgarrah, Yinggan Zheng, Darren K. Mcguire, Eberhard Standl, Paul Armstrong, Eric D. Peterson, Adrian F. Hernandez, Rury R. Holman, Svati H. Shah

Summary: This study reveals the heterogeneity of major adverse cardiovascular event (MACE) risk in individuals with type 2 diabetes mellitus (T2D) and identifies circulating metabolites reflecting mitochondrial dysfunction that can predict incident MACE. These metabolites remain associated with MACE in multivariate models and show favorable changes with exenatide therapy. The findings suggest that these biomarkers may improve cardiovascular risk prediction models and highlight emerging risk mechanisms.

JCI INSIGHT (2023)

Article Psychology, Clinical

All the Same? Different Measures of Personality Functioning Are Similar but Distinct. A Comparative Study from a Psychodynamic Perspective Using Exploratory Graph Analysis

Larissa Vierl, Susanne Hoerz-Sagstetter, Cord Benecke, Carsten Spitzer, Florian Juen

Summary: This study compares two widely used questionnaires based on psychodynamic theories for assessing personality functioning (PF), finding that while highly correlated, they tap into distinct domains of PF. Exploratory Graph Analysis (EGA) and bootEGA were used to explore the dimensionality and stability of the questionnaires. These findings have important implications for clinical and scientific practice.

JOURNAL OF PERSONALITY ASSESSMENT (2023)

Article Medicine, Research & Experimental

Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2

Nandini Avula, Dustin Kakach, Christopher J. Tignanelli, David M. Liebovitz, Jacinda M. Nicklas, Kenneth Cohen, Michael A. Puskarich, Hrishikesh K. Belani, John B. Buse, Nichole R. Klatt, Blake Anderson, Amy B. Karger, Katrina M. Hartman, Barkha Patel, Sarah L. Fenno, Neha V. Reddy, Spencer M. Erickson, David R. Boulware, Thomas A. Murray, Carolyn T. Bramante

Summary: The COVID-19 pandemic has led to the advancement of decentralized clinical trials (DCT). DCTs have proved to be an effective and pragmatic method for assessing health outcomes during the pandemic. This report highlights the successful implementation of the COVID-OUT trial, which utilized decentralized strategies to rapidly deliver study drugs and remotely monitor participant outcomes.

JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE (2023)

Article Medicine, Research & Experimental

Case study of semaglutide and cardiovascular outcomes: An application of the Causal Roadmap to a hybrid design for augmenting an RCT control arm with real-world data

Lauren E. Dang, Edwin Fong, Jens Magelund Tarp, Kim Katrine Bjerring Clemmensen, Henrik Ravn, Kajsa Kvist, John B. Buse, Mark van der Laan, Maya Petersen

Summary: This study presents three designs for evaluating the difference in risk of major adverse cardiovascular events between oral semaglutide and standard-of-care. Simulation results show that Designs 1 and 2 perform similarly, while Design 3 integrates external controls in 84% of cross-validation folds. The estimated risk difference using Design 3 is -1.53%-points.

JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE (2023)

Article Medicine, Research & Experimental

Enrollment of underrepresented racial and ethnic groups in the Rare and Atypical Diabetes Network (RADIANT)

Mustafa Tosur, Laura Gandolfo, Ashok Balasubramanyam, Rochelle N. Naylor, Toni I. Pollin, Neda Rasouli, Sara J. Cromer, John B. Buse, Maria J. Redondo

Summary: The incidence of diabetes in underrepresented racial and ethnic groups is increasing and has worse outcomes compared to non-Hispanic White individuals. This study aimed to recruit a diverse study population, however, the participation of underrepresented groups was low. Strategies to enhance their recruitment and retention are needed.

JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE (2023)

暂无数据